Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crispr Therapeutics Ag
(NQ:
CRSP
)
48.69
+1.19 (+2.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crispr Therapeutics Ag
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
28
29
Next >
Wall Street Estimates That CRISPR Therapeutics Stock Could Jump 49%. Here's Why That's Right.
June 27, 2023
With two huge catalysts drawing near, its stock could go even higher.
Via
The Motley Fool
What Is CRISPR And Why Should Your Portfolio Care?
June 25, 2023
CRISPR Therapeutics continues to be at the forefront of CRISPR-based therapeutics development. It's the first, and largest, but not the only player.
Via
Talk Markets
3 Monster Stocks in the Making to Buy Right Now
June 25, 2023
They're not monsters now -- but just give them some time.
Via
The Motley Fool
Alleged Industrial Espionage Makes an Interesting Story
June 21, 2023
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
Via
The Motley Fool
Cathie Wood Is Buying This Growth Stock and Selling Its Competitor. Should You Follow Suit?
June 21, 2023
There's more than one reason to sell a stock while buying another.
Via
The Motley Fool
Is CRISPR Therapeutics Stock a Buy Now?
June 21, 2023
CRISPR stock has climbed more than 40% so far this year.
Via
The Motley Fool
Where Will CRISPR Therapeutics Be in 10 Years?
June 14, 2023
The biotech is part of a revolution in gene-editing therapies.
Via
The Motley Fool
What 17 Analyst Ratings Have To Say About CRISPR Therapeutics
June 09, 2023
Via
Benzinga
Can This Gene-Editing Stock Deliver 10X Returns?
June 08, 2023
Buying shares of Intellia Therapeutics might be a smart move.
Via
The Motley Fool
Buying This Growth Stock Hand-Over-Fist Right Now Could Make You a Lot Wealthier by 2030
June 21, 2023
This company has several catalysts for growth coming up, with more on the way.
Via
The Motley Fool
3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever
June 20, 2023
Here are three long-term biotech stock investments that have the opportunity to turn risk -tolerant investors into millionaires.
Via
InvestorPlace
Here's the Secret Behind Cathie Wood's Latest Moneymaking Strategy
June 18, 2023
Success could be in the DNA of the Ark Invest founder.
Via
The Motley Fool
How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities
June 17, 2023
The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators...
Via
Talk Markets
3 Cathie Wood Investments That Could Deliver Superior Returns
June 17, 2023
These three stocks fit Wood's profile for big-time growth.
Via
The Motley Fool
2 Short-Squeeze Candidates That Could Go Parabolic
June 15, 2023
Editas Medicine and Bluebird Bio have been favorite targets for short-sellers lately.
Via
The Motley Fool
This Move Is a First for the FDA. Could It Signal a Big Turning Point for CRISPR Therapeutics?
June 13, 2023
All eyes are on CRISPR Therapeutics' gene editing technology.
Via
The Motley Fool
5 Stocks to Buy With Explosive 500% Potential
June 12, 2023
Take advantage of a bullish change in investor sentiment with these five stocks to buy for 500% upside potential.
Via
InvestorPlace
2 Biotech Stocks That Could Help Make You a Fortune
June 12, 2023
Biotech stocks with cutting-edge therapies have the potential to generate substantial returns over time.
Via
The Motley Fool
3 No-Brainer Stocks to Buy in June
June 10, 2023
These biopharma stocks could be big winners.
Via
The Motley Fool
Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics' Exa-cel Application
June 09, 2023
The FDA has accepted the application for Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG (NASDAQ: CRSP) exa-cel for sickle cell disease and transfusion-dependent
Via
Benzinga
Vertex/CRISPR Partnered Cell Therapy Shows Encouraging In Sickle Cell Disease, Thalassemia Patients
June 09, 2023
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and CRISPR Therapeutics AG (NASDAQ: CRSP) announced that pivotal trials for exagamglogene autotemcel (exa-cel) for transfusion-dependent...
Via
Benzinga
Carvana (CVNA) Stock Continues to Move on Improved Outlook
June 09, 2023
Carvana (CVNA) stock is still a hot topic among traders on Friday after the used-car retailer updated its outlook yesterday.
Via
InvestorPlace
TGT Stock Alert: Have Target’s Sales Numbers Peaked?
June 09, 2023
Target (TGT) stock is in hot water on Friday after Citi analyst Paul Lejuez warned investors to stay away from the retailer.
Via
InvestorPlace
Why Is CRISPR Therapeutics (CRSP) Stock Moving Today?
June 09, 2023
CRISPR Therapeutics (CRSP) stock is on the move Friday after the company revealed data from its CLIMB-111 and CLIMB-121 clinical trials.
Via
InvestorPlace
Crispr Stock Slips; The FDA Could Approve The First CRISPR-Based Gene-Editing Drug In Just Six Months
June 09, 2023
The agency said it will make an approval decision on Crispr's exa-cel in December.
Via
Investor's Business Daily
Wall Street Loves These 3 Growth Stocks -- Should You?
June 09, 2023
Analysts think all three of these stocks could soar.
Via
The Motley Fool
Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress
June 09, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
June 08, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
June 08, 2023
Today, CRISPR has reached an important turning point.
Via
The Motley Fool
Cathie Wood Is Buying the SEC Lawsuit Dip in Coinbase (COIN) Stock
June 07, 2023
Coinbase and the crypto industry at large is at war with regulators. But Cathie Wood is still buying shares of COIN stock.
Via
InvestorPlace
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.